NCT02790450View on ClinicalTrials.gov

Acute Effects of Benzbromaron on the Pulmonary Circulation

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Idiopathic Pulmonary Arterial Hypertension
Interventions
DRUG

Benzbromarone

1x200mg Benzbromarone will be applied after baseline measurements during right heart catheterization. The effects of the drug on the pulmonary hemodynamics will be assessed after 2 hours.

Trial Locations (1)

8036

Medical University of Graz, Graz

All Listed Sponsors
collaborator

Ludwig Boltzmann Institute for Lung Vascular Research

OTHER

lead

Medical University of Graz

OTHER

NCT02790450 - Acute Effects of Benzbromaron on the Pulmonary Circulation | Biotech Hunter | Biotech Hunter